Journal of Applied Toxicology · 2017 · 15 citations · 43 references
PharmacyDermatologyToxicologyHepatotoxicologyInflammationPharmaceutical ToxicologyCytokine BiologyDermal ToxicityDrug-induced Skin ReactionsHepatotoxicity MechanismsInflammatory SignalingMolecular Mechanisms Of ToxicityCutaneous Drug ReactionsCytokine-mediated Skin InflammationDrug-induced Liver Injury BiomarkersHepatotoxic MechanismsKeratinocyte ActivationKeratinocyte Immune SignalingMechanisms Of Drug-induced InjurySerious Adverse Drug Reactions
Drug-induced liver injury (DILI) is one of the most common adverse drug reactions. DILI is often accompanied by skin reactions, including rash and pruritus. However, it is still unknown whether DILI-associated genes such as S100 calcium-binding protein A and interleukin (IL)-1β are involved in drug-induced skin toxicity. In the present study, most of the tested hepatotoxic drugs such as pioglitazone and diclofenac induced DILI-associated genes in human and mouse keratinocytes. Keratinocytes of mice at higher risk for DILI exhibited an increased IL-1β basal expression. They also showed a higher inducibility of IL-1β when treated by pioglitazone. Mice at higher risk for DILI showed even higher sums of DILI-associated gene basal expression levels and induction rates in keratinocytes. Our data suggest that DILI-associated genes might be involved in the onset and progression of drug-induced skin toxicity. Furthermore, we might be able to identify individuals at higher risk of developing DILI less invasively by examining gene expression patterns in keratinocytes. Copyright © 2017 John Wiley & Sons, Ltd.
43
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Gout-associated uric acid crystals activate the NALP3 inflammasome
Fabio Martinon, Virginie Pétrilli, Annick Mayor et al. · Nature · 2006 · 5.2K citations